Nomura Asset Management International’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$83.3M Buy
3,457,889
+402,470
+13% +$10.5M 0.13% 201
2026
Q1
$85.8M Buy
3,055,419
+730,674
+31% +$19.5M 0.15% 184
2025
Q4
$57.9M Buy
+2,324,745
New +$58.6M 0.09% 315

Other funds holding PFE

Nomura Asset Management International's PFE Position: Q2 2026 in Review

Nomura Asset Management International increased its Pfizer (PFE) stake by 13% in Q2 2026, buying an estimated $10.5M and bringing the position to 3,457,889 shares worth $83.3M. The position accounts for 0.13% of the portfolio, ranked #201.

Nomura Asset Management International first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $85.8M in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Nomura Asset Management International held 3,457,889 shares of Pfizer worth $83.3M as of Q2 2026.
  • Nomura Asset Management International bought 402,470 Pfizer shares in Q2 2026, an estimated $10.5M.
  • Pfizer made up 0.13% of Nomura Asset Management International's portfolio in Q2 2026, its #201 holding.
  • Nomura Asset Management International first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • Nomura Asset Management International's Pfizer position peaked at $85.8M in Q1 2026.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Nomura Asset Management International's 13F filing for Q2 2026, filed 14 Aug 2026.